If you need more lookups,
subscriptions start at $34 USD/month.
Michael Engsig Location
Copenhagen, DK
Michael Engsig Work
2019 -now CEO @
2023 -now Board Member @
2019 -2019 Chief Operating Officer @
2017 -2019 EVP Drug Development Counselling and Business Development @
2015 -2016 Executive Director - Area Head Clinical Management Central and Eastern Europe @
2014 -2015 Commercial Lead Established Products in Emerging Markets @
2011 -2014 Head of Takeda-Nycomed Russian Innovation Center @
2007 -2011 Senior Director, Head of Clinical Operations @
2007 -2007 Head of R and D Integration Office @
2005 -2006 Head of Business Support and Portfolio Management @
2003 -2005 Project Manager @
2002 -2003 Equity Analyst @
1998 -2002 Project Manager @
Michael Engsig Education
Copenhagen Business School
Graduate Diploma in Business Administration (Organisation and Leadership)
1998-2001
DTU - Technical University of Denmark
M.Sc. (Biochemistry)
1992-1998
Michael Engsig Skills
Change Leadership
Strategic Leadership
Strategy Development
Pharmaceutical Industry
Clinical Development
Lifesciences
Clinical Trials
GCP
Drug Discovery
Cross-functional Team Leadership
CRO
R&D
Drug Development
Change Management
Strategy
Biotechnology
Life Sciences
Leadership
Regulatory Affairs
Therapeutic Areas
Clinical Research
Sales
Cross Functional Team Leadership
Business Development
Portfolio Management
Business Analysis
Customer Service
Michael Engsig Summary
Michael Engsig, based in Copenhagen, DK, is currently a CEO at Nykode Therapeutics. Michael Engsig brings experience from previous roles at FluoGuide A/S, Vaccibody AS, KLIFO A/S and PPD. Michael Engsig holds a 1998 - 2001 Graduate Diploma in Business Administration in Organisation and Leadership @ Copenhagen Business School. With a robust skill set that includes Change Leadership, Strategic Leadership, Strategy Development, Pharmaceutical Industry, Clinical Development and more. Michael Engsig has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Michael Engsig?
Find contact details for 700 million professionals.